Based on your request and saved instructions, here is the information for the product Tetrazin 25mg Tablet.

Please note: Tetrazin 25mg Tablet contains the active ingredient Tetrabenazine and is a prescription medication primarily used to manage involuntary movements. It is important to consult a healthcare professional for specific medical advice, dosage, and treatment.

📝 Product Information

Meta Title

Tetrazin 25mg Tablet | High-Strength Tetrabenazine for Chorea in Huntington's Disease

Meta Description

Purchase Tetrazin 25mg (Tetrabenazine) tablets for effective, higher-dose symptomatic management of chorea, the involuntary, uncontrolled movements associated with Huntington's disease. Used to optimize movement control in patients.

Meta Keywords (Huge Quantity)

Tetrazin 25mg, Tetrazin, Tetrabenazine, Tetrabenazine 25mg, Chorea treatment, Huntington's disease, involuntary movements, hyperkinetic disorders, VMAT-2 inhibitor, movement disorder medication, chorea symptoms, central nervous system depressant, chorea relief, neurologic disorder treatment, CNS depressant, Tetrabenazine high strength, movement control, Beacon Pharmaceuticals, neuroleptic, abnormal body movements, chorea in HD, tetrabenazine dosage, tetrabenazine uses, tetrabenazine benefits, chorea medication, tetrabenazine for HD, movement disorder drug, neurologic treatment, controlled movements, tetrabenazine 25 mg, Huntington's chorea, extrapyramidal symptoms, dyskinesia, tardive dyskinesia, motor symptoms, hyperkinesia, neurological symptoms, movement disorder management, tetrabenazine oral, prescription medication, brain chemicals, dopamine depletion, monoamine depletion, basal ganglia, synaptic vesicles, movement control, Tetrabenazine for movement disorders, strong chorea relief, VMAT2 inhibitor, higher dose chorea control, Tetrabenazine management, neurodegenerative movement, drug for hyperkinesia, VMAT2 blocker

Product Benefits

• Effective Chorea Reduction: Contains the higher 25mg dose of Tetrabenazine, typically used as part of a titrated regimen to achieve optimal reduction of chorea (uncontrolled, jerky, involuntary movements) associated with Huntington's disease.

• Targeted Movement Regulation: Works by reversibly inhibiting the vesicular monoamine transporter type 2 (VMAT-2), leading to a controlled depletion of monoamine neurotransmitters (like dopamine) in the brain, thereby moderating excessive motor activity.

• Optimized Dosing Flexibility: The 25mg strength supports flexible dosing, often administered in divided doses (up to three times daily) as part of a personalized titration schedule supervised by a specialist to balance therapeutic effect and tolerability.

• Symptomatic Improvement: Does not cure the underlying cause of Huntington's disease but provides significant symptomatic relief from the movement disorder, which can improve daily function and quality of life.